Archive for the ‘Scientific Meetings & Publications’ Category

New Data on Obesity and Cancer in Young Persons

January 18, 2024 — Cancer is rising in young persons and it appears that obesity is playing a role. Of course, this is not to say that obesity tells the whole story. Cancer prevalence patterns present a complex puzzle – just as obesity prevalence does. A Continuing Shift Toward Younger Persons Yesterday in CA: A Cancer Journal for Clinicians, […]

Incentives for Metabolic Surgery in Response to GLP-1 Medicines

January 17, 2024 — Over the past year, as the world has embraced GLP-1 medicines like semaglutide for obesity, we have heard much speculation about dire prospects for the future of metabolic surgery. Stock prices dropped earlier this year for medical device companies with big investments in bariatric surgery when Intuitive Surgical announced they were seeing a slowdown in […]

Should We Care That We’re Drinking Nanoplastics?

January 13, 2024 — A new study this week in Proceedings of the National Academy of Science tells us that every bottle of water we’re drinking has hundreds of thousands of nanoplastics. Should we care? A Blank Slate, Tough to Study This study is important simply because it fills a void in knowledge about how much these nanoplastics are […]

Cutting Food for Kids with an Obesity Excuse

January 12, 2024 — This is a new political fashion we hope will quickly find its place in the discards bin. Iowa Governor Kim Reynolds is declining federal summer food aid for kids saying, “An EBT card does nothing to promote nutrition at a time when childhood obesity has become an epidemic.” USDA this summer will launch a permanent […]

Lancet: Obesity Drugs Won’t Save Us from Cheeseburgers

January 10, 2024 — Some things never change. Half a century ago, editors of the Lancet proclaimed that “most obesity could, with care, be prevented.” Drugs have “limited usefulness” for treating obesity, they explained, and so, “we need to be more vigilant about preventing obesity throughout childhood.” After 50 years of relying on this advice, obesity prevalence has tripled. […]

Buyer Beware: Compounded and Fake Semaglutide

January 9, 2024 — Unfortunately, we are facing the new year with a great demand for advanced new obesity medicines and an inadequate supply. On the FDA drug shortages website, all strengths of the Wegovy brand, except 2.4 mg, have limited availability. Both Wegovy and Ozempic are “currently in shortage.” This opens the door for compounded semaglutide and a […]

Will GLP-1 Medicines Widen the Economic Rift in Health?

January 8, 2024 — Right now, the promise of GLP-1 medicines for obesity, though revolutionary, is serving only to widen the economic rift in health. People with extraordinary wealth or generous health insurance plans receive the health benefits that flow from treating obesity effectively – which include a longer life, fewer strokes, and fewer heart attacks. Others are consigned […]

Food Noise: All in the Ears of the Listener?

January 6, 2024 — We are hearing a cacophony lately – lots of noise about food noise. Part of what we hear is a celebration. Some people are finding blessed relief from it when they take advanced medicines for obesity like semaglutide or tirzepatide. Others see a threat in the relief that those people are finding. They deny that […]

Obesity Care: A Roadmap for Employers

January 3, 2024 — One of the big trends for this year will be increasing access to obesity care. That means more and more employers will be adding obesity care to the their health benefit plans. Yes, there will be much squawking about the list price for advanced obesity medicines. That’s perfectly normal and good. But the fact is […]

Is Obesity Causing Us Stress or Is Stress Causing Obesity?

December 31, 2023 — “We have found a way to soothe the pain of living in this society by stimulating the reward pathway with unhealthy foods just as people do with alcohol and drugs.” This blunt obserservation landed in our inbox with a thud from obesity scientist and clinician Caroline Apovian last week. A counterbalance to the optimistic talk […]